| |
| |
|
| Insider
Information: |
Mcwilliams David |
| Relationship: |
Director |
| City: |
Tomball |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
686,557 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$8,572,874 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
686,557 |
|
|
| Total
Value |
$8,572,874 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
| Percentage
Gain/Loss : |
 446.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acer Therapeutics Inc |
ACER |
CEO, Director |
2005-12-14 |
66,256 |
2005-02-08 |
0 |
Premium* |
|
|
Greenwich Lifesciences, Inc. |
GLSI |
Director |
2021-12-14 |
620,301 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GLSI |
Greenwich Lifesciences, I... |
Director |
– • – |
2021-12-14 |
4 |
B |
$27.56 |
$5,512 |
D/D |
200 |
620,301 |
2.39 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
Director |
– • – |
2020-11-20 |
4 |
B |
$5.40 |
$8,100 |
D/D |
1,500 |
620,101 |
2.39 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
Director |
– • – |
2020-09-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
171,622 |
618,601 |
0 |
- |
|
| GLSI |
Greenwich Lifesciences, I... |
Director |
– • – |
2020-09-29 |
4 |
B |
$5.75 |
$14,996 |
D/D |
2,608 |
446,979 |
2.39 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
Director |
– • – |
2020-09-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
444,371 |
|
- |
|
| ACER |
Acer Therapeutics Inc |
officerTitle |
• • – |
2005-12-14 |
4 |
B |
$0.63 |
$1,260 |
D/D |
2,000 |
66,256 |
2.73 |
- |
|
| ACER |
Acer Therapeutics Inc |
CEO |
• • – |
2005-07-18 |
4 |
B |
$0.00 |
$0 |
D/D |
23,334 |
64,256 |
2.73 |
- |
|
| ACER |
Acer Therapeutics Inc |
CEO |
• • – |
2005-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
36,922 |
40,922 |
|
- |
|
| ACER |
Acer Therapeutics Inc |
CEO |
• • – |
2005-02-08 |
4 |
B |
$0.00 |
$0 |
D/D |
1,500 |
4,000 |
2.73 |
- |
|
| ACER |
Acer Therapeutics Inc |
CEO |
• • – |
2004-11-02 |
5 |
B |
$0.00 |
$0 |
D/D |
2,500 |
2,500 |
0 |
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
